Mylin L M, Bonneau R H, Lippolis J D, Tevethia S S
Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey 17033, USA.
J Virol. 1995 Nov;69(11):6665-77. doi: 10.1128/JVI.69.11.6665-6677.1995.
Simian virus 40 large tumor (T) antigen contains three H-2Db-restricted (I, II/III, and V) and one H-2Kb-restricted (IV) cytotoxic T lymphocyte (CTL) epitopes. We demonstrate that a hierarchy exists among these CTL epitopes, since vigorous CTL responses against epitopes I, II/III, and IV are detected following immunization of H-2b mice with syngeneic, T-antigen-expressing cells. By contrast, a weak CTL response against the H-2Db-restricted epitope V was detected only following immunization of H-2b mice with epitope loss variant B6/K-3,1,4 cells, which have lost expression of CTL epitopes I, II/III, and IV. Limiting-dilution analysis confirmed that the lack of epitope V-specific CTL activity in bulk culture splenocytes correlated with inefficient expansion and priming of epitope V-specific CTL precursors in vivo. We examined whether defined genetic alterations of T antigen might improve processing and presentation of epitope V to the epitope V-specific CTL clone Y-5 in vitro and/or overcome the recessive nature of epitope V in vivo. Deletion of the H-2Db-restricted epitopes I and II/III from T antigen did not increase target cell lysis by epitope V-specific CTL clones in vitro. The amino acid sequence SMIKNLEYM, which species an optimized H-2Db binding motif and was found to induce CTL in H-2b mice, did not further reduce epitope V presentation in vitro when inserted within T antigen. Epitope V-containing T-antigen derivatives which retained epitopes I and II/III or epitope IV did not induce epitope V-specific CTL in vivo: T-antigen derivatives in which epitope V replaced epitope I failed to induce epitope V-specific CTL. Recognition of epitope V-H-2Db complexes by multiple independently derived epitope V-specific CTL clones was rapidly and dramatically reduced by incubation of target cells in the presence of brefeldin A compared with the recognition of the other T-antigen CTL epitopes by epitope specific CTL, suggesting that the epitope V-H-2Db complexes either are labile or are present at the cell surface at reduced levels. Our results suggest that processing and presentation of epitope V is not dramatically altered (reduced) by the presence of immunodominant CTL epitopes in T antigen and that the immunorecessive nature of epitope V is not determined by amino acids which flank its native location within simian virus 40 T antigen.
猿猴病毒40大T抗原包含三个受H-2Db限制的(I、II/III和V)以及一个受H-2Kb限制的(IV)细胞毒性T淋巴细胞(CTL)表位。我们证明这些CTL表位之间存在等级关系,因为在用同基因的、表达T抗原的细胞免疫H-2b小鼠后,能检测到针对表位I、II/III和IV的强烈CTL反应。相比之下,仅在用表位缺失变体B6/K-3,1,4细胞免疫H-2b小鼠后,才检测到针对受H-2Db限制的表位V的微弱CTL反应,该变体已失去CTL表位I、II/III和IV的表达。有限稀释分析证实,大量培养的脾细胞中缺乏表位V特异性CTL活性与体内表位V特异性CTL前体的低效扩增和启动相关。我们研究了T抗原特定的基因改变是否可能在体外改善表位V向表位V特异性CTL克隆Y-5的加工和呈递,以及/或者在体内克服表位V的隐性性质。从T抗原中删除受H-2Db限制的表位I和II/III,在体外并未增加表位V特异性CTL克隆对靶细胞的裂解。氨基酸序列SMIKNLEYM,它构成了一个优化的H-2Db结合基序,并且在H-2b小鼠中能诱导CTL,当插入T抗原内时,在体外并未进一步降低表位V的呈递。保留表位I和II/III或表位IV的含表位V的T抗原衍生物在体内未诱导表位V特异性CTL:表位V取代表位I的T抗原衍生物未能诱导表位V特异性CTL。与表位特异性CTL对其他T抗原CTL表位的识别相比,在布雷菲德菌素A存在下孵育靶细胞,多个独立衍生的表位V特异性CTL克隆对表位V-H-2Db复合物的识别迅速且显著降低,这表明表位V-H-2Db复合物要么不稳定,要么在细胞表面的水平降低。我们的结果表明,T抗原中免疫显性CTL表位的存在不会显著改变(降低)表位V的加工和呈递,并且表位V的免疫隐性性质不是由其在猿猴病毒40 T抗原中天然位置侧翼的氨基酸决定的。